scholarly journals Antioxidant Therapies in the Prevention and Treatment of Atrial Fibrillation

Author(s):  
Tong Liu ◽  
Panagiotis Korantzopoulos ◽  
Guangping Li
1972 ◽  
Vol 10 (7) ◽  
pp. 25-28 ◽  

Some of the indications for anticoagulant therapy remain controversial, but they are widely used for the prevention and treatment of thrombosis and embolism after surgery1 and after myocardial infarction,2 in patients with atrial fibrillation, and in those with transient cerebral ischaemia.3 This article discusses the drugs available for long-term use. Those suitable for immediate and short-term use, heparin and arvin, will be discussed in the next issue.


2018 ◽  
Vol 43 (6) ◽  
pp. 241-283 ◽  
Author(s):  
Paul A. Rogers ◽  
Michael L. Bernard ◽  
Christopher Madias ◽  
Sudarone Thihalolipavan ◽  
N.A. Mark Estes ◽  
...  

2007 ◽  
Vol 42 (8) ◽  
pp. 680-685
Author(s):  
Patricia A. Howard ◽  
Brian J. Barnes

This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the United States, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on prevention and treatment—if they keep current with developments in drug therapy.


Sign in / Sign up

Export Citation Format

Share Document